The PE Ratio as of December 2024 (TTM) for Applied Therapeutics, Inc. (APLT) is -0.60

According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.60. This represents a change of -114.66% compared to the average of 4.09 of the last 4 quarters.

Applied Therapeutics, Inc. (APLT) Historical PE Ratio (quarterly & annually)

How has APLT PE Ratio performed in the past?

The mean historical PE Ratio of Applied Therapeutics, Inc. over the last ten years is -6.16. The current -0.60 PE Ratio has changed 873.69% with respect to the historical average. Over the past ten years (40 quarters), APLT's PE Ratio was at its highest in in the June 2024 quarter at 19.62. The PE Ratio was at its lowest in in the March 2020 quarter at -13.77.

Applied Therapeutics, Inc. (APLT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Applied Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied Therapeutics, Inc. (APLT) Average PE Ratio

How has APLT PE Ratio performed in the past?

The current PE Ratio of Applied Therapeutics, Inc. (APLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Applied Therapeutics, Inc. (APLT) PE Ratio vs. Peers

How is APLT’s PE Ratio compared to its peers?

Applied Therapeutics, Inc.’s PE Ratio is greater than X4 Pharmaceuticals, Inc. (-6.95), less than Galera Therapeutics, Inc. (-0.08), greater than Terns Pharmaceuticals, Inc. (-5.12), greater than Day One Biopharmaceuticals, Inc. (-14.52), less than HOOKIPA Pharma Inc. (-0.55), less than Lyra Therapeutics, Inc. (-0.12), greater than Shattuck Labs, Inc. (-0.76), less than Vincerx Pharma, Inc. (-0.32), less than BioAtla, Inc. (-0.37), greater than Gain Therapeutics, Inc. (-1.97), less than TFF Pharmaceuticals, Inc. (-0.02), greater than aTyr Pharma, Inc. (-2.33), less than IN8bio, Inc. (-0.35), greater than Lantern Pharma Inc. (-1.76), greater than Anebulo Pharmaceuticals, Inc. (-5.30), greater than Acrivon Therapeutics, Inc. Common Stock (-3.08), greater than PMV Pharmaceuticals, Inc. (-1.47), greater than Molecular Partners AG (-2.46), greater than Mineralys Therapeutics, Inc. (-4.16), greater than Seer, Inc. (-1.64), greater than ORIC Pharmaceuticals, Inc. (-4.82), greater than Cullinan Oncology, Inc. (-4.99), greater than C4 Therapeutics, Inc. (-2.55),

Build a custom stock screener for Applied Therapeutics, Inc. (APLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Therapeutics, Inc. (APLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.